Ken M. Kosak

Prevention of Experimental Coronavirus Colds with Intranasal  -2b Interferon

Ronald B. Turner, A. Felton, Ken M. Kosak et al. · The Journal of Infectious Diseases · 1986 · 92 citations · Full text

The Nitric Oxide Prodrug JS-K Is Effective against Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo: Involvement of Reactive Oxygen Species

Anna Maciąg, Harinath Chakrapani, Joseph E. Saavedra et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 68 citations · Full text

Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemia

Tibor Kovacsovics, Alice S. Mims, Mohamed E. Salama et al. · Blood Advances · 2018 · 56 citations · Full text

A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker

Kristen Kelley, Kenneth Grossman, Mary Brittain-Blankenship et al. · BMC Cancer · 2021 · 46 citations · Full text

JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C)

Paul J. Shami, Anna Maciąg, Jordan K. Eddington et al. · Leukemia Research · 2009 · 30 citations · Full text

Medicinal Chemistry, Reactive Nitrogen Specie, Nitric Oxide +9